Jamie Weishaar is an experienced business development executive leader specializing in pharmaceutical drug development, including contract research development and manufacturing (CRDMO) services. He is focused on accelerating drug product development, with Quotient Sciences' full range of early drug product, clinical manufacturing, and commercial drug product manufacturing services.

Jamie holds a degree in Chemistry from Fort Hays State University and Masters in Analytical Chemistry from Washington State University.